Harvard Bioscience, Inc. announced a labor force reduction to improve its operating cost structure and support its ongoing investments in growth. The Company expects to realize overall annual run rate savings of approximately $4 million beginning in the second quarter of 2024. The Company also expects second quarter restructuring-related charges of approximately $0.5 million.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.48 USD | +0.87% | -2.25% | -34.95% |
May. 07 | Transcript : Harvard Bioscience, Inc., Q1 2024 Earnings Call, May 07, 2024 | |
May. 07 | Earnings Flash (HBIO) HARVARD BIOSCIENCE Posts Q1 Revenue $24.5M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-34.95% | 150M | |
+12.71% | 229B | |
+13.88% | 195B | |
+18.46% | 142B | |
+29.11% | 109B | |
+3.12% | 64.85B | |
+19.08% | 54.33B | |
+7.04% | 52.09B | |
+10.85% | 45.15B | |
+4.94% | 37.39B |
- Stock Market
- Equities
- HBIO Stock
- News Harvard Bioscience, Inc.
- Harvard Bioscience, Inc. Announces Action to Improve Operational Efficiency and Support Ongoing Investments in Growth